Endocrine Control of Growth

被引:88
作者
Murray, Philip G. [1 ]
Clayton, Peter E. [2 ,3 ]
机构
[1] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland
[2] Univ Manchester, Manchester M13 9PL, Lancs, England
[3] Royal Manchester Childrens Hosp, Manchester M13 9WL, Lancs, England
关键词
growth; growth hormone; IGF-1; puberty; CONGENITAL LEPTIN DEFICIENCY; HORMONE-BINDING-PROTEIN; FACTOR-I; 3-M SYNDROME; PRIMORDIAL DWARFISM; POSTNATAL-GROWTH; SEX STEROIDS; BONE-GROWTH; RECEPTOR; GENE;
D O I
10.1002/ajmg.c.31357
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Human growth is a complex process starting at conception and completing in adolescence at the time of growth plate fusion. Growth can be divided into four phases: (1) fetal, where the predominant endocrine factors controlling growth are insulin and the insulin-like growth factors. (2) Infancy, where growth is mainly dependent upon nutrition. (3) Childhood, where the growth hormoneinsulin-like growth factor-I (GH-IGF-I) axis and thyroid hormone are most important. (4) Puberty, where along with the GH-IGF-I axis the activation of the hypothalamo-pituitarygonadal axis to generate sex steroid secretion becomes vital to the completion of growth. GH is released from the pituitary in a pulsatile fashion under the control of GHRH, Ghrelin, and somatostatin and, via a complex signal transduction cascade, initiates the release of IGF-I within many tissues but predominantly the liver and at the growth plate. IGF-I acts in an autocrine and paracrine manner via the IGF-I receptor to stimulate cell proliferation and longitudinal growth. Activation of the pituitarygonadal axis during puberty occurs via a complex interaction of factors including kisspeptin, leptin, gonadotrophin releasing hormone, and tachykinin ultimately leading to augmentation of GH secretion, the pubertal growth spurt, and fusion of the growth plates. Many other hormones can affect the GH-IGF-I system or directly affect cell proliferation at the growth plate including thyroid hormone, vitamin D, and corticosteroids. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:76 / 85
页数:10
相关论文
共 80 条
[21]   STUDIES OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II BY SPECIFIC RADIOLIGAND ASSAYS IN UMBILICAL-CORD BLOOD [J].
GLUCKMAN, PD ;
JOHNSONBARRETT, JJ ;
BUTLER, JH ;
EDGAR, BW ;
GUNN, TR .
CLINICAL ENDOCRINOLOGY, 1983, 19 (03) :405-413
[22]   The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans [J].
Gnanapavan, S ;
Kola, B ;
Bustin, SA ;
Morris, DG ;
McGee, P ;
Fairclough, P ;
Bhattacharya, S ;
Carpenter, R ;
Grossman, AB ;
Korbonits, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2988-2991
[23]   Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling [J].
Hanson, D. ;
Murray, P. G. ;
Coulson, T. ;
Sud, A. ;
Omokanye, A. ;
Stratta, E. ;
Sakhinia, F. ;
Bonshek, C. ;
Wilson, L. C. ;
Wakeling, E. ;
Temtamy, S. A. ;
Aglan, M. ;
Rosser, E. M. ;
Mansour, S. ;
Carcavilla, A. ;
Nampoothiri, S. ;
Khan, W. I. ;
Banerjee, I. ;
Chandler, K. E. ;
Black, G. C. M. ;
Clayton, P. E. .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2012, 49 (03) :267-275
[24]   Exome Sequencing Identifies CCDC8 Mutations in 3-M Syndrome, Suggesting that CCDC8 Contributes in a Pathway with CUL7 and OBSL1 to Control Human Growth [J].
Hanson, Dan ;
Murray, Philip G. ;
O'Sullivan, James ;
Urquhart, Jill ;
Daly, Sarah ;
Bhaskar, Sanjeev S. ;
Biesecker, Leslie G. ;
Skae, Mars ;
Smith, Claire ;
Cole, Trevor ;
Kirk, Jeremy ;
Chandler, Kate ;
Kingston, Helen ;
Donnai, Dian ;
Clayton, Peter E. ;
Black, Graeme C. M. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2011, 89 (01) :148-153
[25]   Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters [J].
Hindmarsh, PC ;
Fall, CHD ;
Pringle, PJ ;
Osmond, C ;
Brook, CGD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2172-2176
[26]   GROWTH-HORMONE SECRETION IN CHILDREN DETERMINED BY TIME-SERIES ANALYSIS [J].
HINDMARSH, PC ;
MATTHEWS, DR ;
BROOK, CGD .
CLINICAL ENDOCRINOLOGY, 1988, 29 (01) :35-44
[27]   GLUCOCORTICOID INHIBITION OF FSH-INDUCED ESTROGEN PRODUCTION IN CULTURED RAT GRANULOSA-CELLS [J].
HSUEH, AJW ;
ERICKSON, GF .
STEROIDS, 1978, 32 (05) :639-648
[28]   Identification of mutations in CUL7 in 3-M syndrome [J].
Huber, C ;
Dias-Santagata, D ;
Glaser, A ;
O'Sullivan, J ;
Brauner, R ;
Wu, K ;
Xu, XS ;
Pearce, K ;
Wang, R ;
Uzielli, MLG ;
Dagoneau, N ;
Chemaitilly, W ;
Superti-Furga, A ;
Dos Santos, H ;
Mégarbané, A ;
Morin, G ;
Gillessen-Kaesbach, G ;
Hennekam, R ;
Van der Burgt, I ;
Black, GCM ;
Clayton, PE ;
Read, A ;
Le Merrer, M ;
Scambler, PJ ;
Munnich, A ;
Pan, ZQ ;
Winter, R ;
Cormier-Daire, V .
NATURE GENETICS, 2005, 37 (10) :1119-1124
[29]   STAT5b deficiency: Lessons from STAT5b gene mutations [J].
Hwa, Vivian ;
Nadeau, Kari ;
Wit, Jan M. ;
Rosenfeld, Ron G. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 25 (01) :61-75
[30]   Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ [J].
Inui, A ;
Asakawa, A ;
Bowers, CY ;
Mantovani, G ;
Laviano, A ;
Meguid, MM ;
Fujimiya, M .
FASEB JOURNAL, 2004, 18 (03) :439-456